Tag: generic drug surveillance
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Alternatives to Sumatriptan: Exploring the Options for Migraine Relief
Mar, 28 2025
Top Motilium Alternatives in 2024 for Effective Nausea Relief
Oct, 28 2024
Prescriber Education Resources: Essential Guides for Doctors on Generic Medications
Jan, 7 2026
Closed-Loop Systems: Automated Insulin Delivery and Real-World Results
May, 7 2026
Vanadium: The Dietary Supplement You Didn't Know You Needed
Sep, 4 2023